BackCellev8 Nutrition Overview

Cellev8 Nutrition Other Current Liabilities

Track Cellev8 Nutrition's other current liabilities ($9.3M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$9.27M

Peer trimmed avg / median

Loading

Cellev8 Nutrition Other Current Liabilities History

Loading

Cellev8 Nutrition vs. peers: Other Current Liabilities Comparison

Loading

Cellev8 Nutrition Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Cellev8 Nutrition (CELV) FAQ

The latest other current liabilities for CELV is $9.3M as of August 2026. In the prior-year period, the figure was $0. Investors often review this figure alongside Cellev8 Nutrition's historical trend and sector peers before judging valuation or financial health.

Over the past year, CELV's other current liabilities moved from $0 to $9.3M. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Cellev8 Nutrition's operating scale or balance-sheet position.

A other current liabilities figure of $9.3M for CELV is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CELV's other current liabilities ($9.3M), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.